南アジアおよび東南アジアの農村地域における熱性疾患の発生率、原因、転帰 (SEACTN-WP-A)
南および東南アジアのコミュニティベースの試験ネットワーク (SEACTN) の一部として、南および東南アジアにおける農村熱性疾患 (RFI) の発生率、原因、および転帰を決定します。ワークパッケージ A (WP-A)。
The study will collect information to understand the causes and outcomes of febrile illness in rural areas in countries across South and Southeast Asia (including Cambodia, Laos, Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that can improve the management of febrile patients in the future.
This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z
調査の概要
状態
条件
詳細な説明
This study aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people living in rural areas in South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI project will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. Determining the incidence, causes and outcomes of febrile illness in these settings will be done through two work packages. The first of these, Work Package A (WP-A), the subject of this study, will be carried out at the community level, primarily by engaging village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities to recruit patients presenting with a febrile illness. These patients will be assessed for presenting symptoms and followed up for clinical outcomes. Collection of specimen for diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by VHWs and HCs in these networks, therefore by using the same process, but also applying blood to filter paper and allowing it to dry (DBS), investigators will test for certain other pathogens, which will increase the aetiological yield.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Battambang、カンボジア
- Action for Health Development (AHEAD)
-
-
-
-
-
Chiang Rai、タイ、57000
- Chiangrai Clinical Research Unit (CCRU)
-
-
Bangkok
-
Ratchathewi、Bangkok、タイ、10400
- Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)
-
-
Changwat Tak
-
Mae Sot、Changwat Tak、タイ、63110
- Shoklo Malaria Research Unit (SMRU)
-
-
-
-
-
Dhaka、バングラデシュ、1212
- Building Resources Across Communities (BRAC)
-
-
-
-
-
Yangon、ビルマ、11201
- Medical Action Myanmar (MAM)
-
-
-
-
Vientiane Prefecture
-
Vientiane、Vientiane Prefecture、ラオス、01000
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients with an acute febrile illness of all ages presenting to village health workers (VHWs) or peripheral health facilities.
説明
Inclusion Criteria:
- Documented fever (≥ 37.5°C axillary), hypothermia (< 35.5°C) and/or history of fever in the last 24 hours.
- Willingness and ability to comply with study protocol for the study duration.
- Written informed consent given to participate in the trial.
Exclusion Criteria:
- Currently enrolled in the study
- Accident or trauma is the cause for presentation
- Presentation ≤ 3 days after routine immunisations
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:CASE_ONLY
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
|---|
|
Patients with febrile illness
Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Local incidence of febrile illness
時間枠:From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level. |
From Months 0 to 24
|
|
Overall incidence of febrile illness
時間枠:From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness. |
From Months 0 to 24
|
|
Mortality
時間枠:Within approximately 1 month of first presentation to the village health worker or health facility
|
Case fatality rates in febrile illness |
Within approximately 1 month of first presentation to the village health worker or health facility
|
|
Morbidity
時間枠:Over 1 month after first presentation
|
Duration of illness in patients presenting with a fever to the village health worker or health facility. |
Over 1 month after first presentation
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Prevalence of pathogens in febrile patients
時間枠:Samples collected over approximately 24 months
|
Pathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots. |
Samples collected over approximately 24 months
|
|
The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.
時間枠:Samples collected over approximately 24 months
|
The area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes. |
Samples collected over approximately 24 months
|
協力者と研究者
スポンサー
協力者
捜査官
- 主任研究者:Yoel Lubell, Prof、Mahidol Oxford Tropical Medicine Research Unit
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.
IPD 共有時間枠
After completion of trial activities and reporting
IPD 共有アクセス基準
MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。